Filed: 5/14/2024ACC: 0000904454-24-000307
📋 What this filing means
FINEPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $389.94M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$389.94M
Total AUM (reported)
34.29M
Total Shares
Allocation by class
COM$134.38M34.5%
COM SER C$107.95M27.7%
SPONSORED ADR$46.24M11.9%
COM NEW$43.14M11.1%
CLASS A ORD$18.13M4.6%
SPON ADR$16.22M4.2%
NOTE 12/1$13.45M3.4%
Portfolio Concentration
Top 3$163.67M42.0%
4–10$135.32M34.7%
11–25$90.95M23.3%
Rest$8.2K0.0%
Top 3 weight
42.0%
Top 10 weight
76.7%
Voting Authority Distribution
Total shares with voting rights: 34.29M
Sole
Full voting authority
34.29M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
LIBERTY BROADBAND CORP
SOLEShares1.89M
TypeSH
Market value$107.95M
27.68%
Sole
1.89M
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares592.53K
TypeSH
Market value$29.16M
7.48%
Sole
592.53K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares175.67K
TypeSH
Market value$26.56M
6.81%
Sole
175.67K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares539.10K
TypeSH
Market value$22.25M
5.71%
Sole
539.10K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares677.10K
TypeSH
Market value$21.82M
5.60%
Sole
677.10K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares158.46K
TypeSH
Market value$20.51M
5.26%
Sole
158.46K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares50K
TypeSH
Market value$19.69M
5.05%
Sole
50K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares360.92K
TypeSH
Market value$18.13M
4.65%
Sole
360.92K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares238.05K
TypeSH
Market value$16.69M
4.28%
Sole
238.05K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares503.76K
TypeSH
Market value$16.22M
4.16%
Sole
503.76K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares840.45K
TypeSH
Market value$15.54M
3.99%
Sole
840.45K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares656.60K
TypeSH
Market value$13.57M
3.48%
Sole
656.60K
Shared
0.00
None
0.00
DISH NETWORK CORPORATION
SOLEShares18.30M
TypePRN
Market value$13.45M
3.45%
Sole
18.30M
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares961.25K
TypeSH
Market value$12.80M
3.28%
Sole
961.25K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares1.65M
TypeSH
Market value$12.72M
3.26%
Sole
1.65M
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares1.49M
TypeSH
Market value$12.37M
3.17%
Sole
1.49M
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares402.40K
TypeSH
Market value$9.97M
2.56%
Sole
402.40K
Shared
0.00
None
0.00
CHURCHILL CAPITAL CORP VII
SOLEShares548K
TypeSH
Market value$175.4K
0.04%
Sole
548K
Shared
0.00
None
0.00
MONEYHERO LIMITED
SOLEShares895K
TypeSH
Market value$108.5K
0.03%
Sole
895K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$70.6K
0.02%
Sole
125K
Shared
0.00
None
0.00
CONCORD ACQUISITION CORP II
SOLEShares408.33K
TypeSH
Market value$45.4K
0.01%
Sole
408.33K
Shared
0.00
None
0.00
COMPASS DIGITAL ACQUISITION CORP
SOLEShares459.91K
TypeSH
Market value$42.3K
0.01%
Sole
459.91K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares655.20K
TypeSH
Market value$34.1K
<0.01%
Sole
655.20K
Shared
0.00
None
0.00
SWIFTMERGE ACQUISITION CORP
SOLEShares490K
TypeSH
Market value$27.4K
<0.01%
Sole
490K
Shared
0.00
None
0.00
YS BIOPHARMA CO LTD
SOLEShares490K
TypeSH
Market value$25.0K
<0.01%
Sole
490K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LIBERTY BROADBAND CORPSOLE | COM SER C | 1.89M | SH | $107.95M 27.68% | 1.89M | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 592.53K | SH | $29.16M 7.48% | 592.53K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 175.67K | SH | $26.56M 6.81% | 175.67K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 539.10K | SH | $22.25M 5.71% | 539.10K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 677.10K | SH | $21.82M 5.60% | 677.10K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 158.46K | SH | $20.51M 5.26% | 158.46K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 50K | SH | $19.69M 5.05% | 50K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 360.92K | SH | $18.13M 4.65% | 360.92K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 238.05K | SH | $16.69M 4.28% | 238.05K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 503.76K | SH | $16.22M 4.16% | 503.76K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 840.45K | SH | $15.54M 3.99% | 840.45K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 656.60K | SH | $13.57M 3.48% | 656.60K | 0.00 | 0.00 |
DISH NETWORK CORPORATIONSOLE | NOTE 12/1 | 18.30M | PRN | $13.45M 3.45% | 18.30M | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 961.25K | SH | $12.80M 3.28% | 961.25K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 1.65M | SH | $12.72M 3.26% | 1.65M | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 1.49M | SH | $12.37M 3.17% | 1.49M | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 402.40K | SH | $9.97M 2.56% | 402.40K | 0.00 | 0.00 |
CHURCHILL CAPITAL CORP VIISOLE | *W EXP 02/29/202 | 548K | SH | $175.4K 0.04% | 548K | 0.00 | 0.00 |
MONEYHERO LIMITEDSOLE | *W EXP 09/13/202 | 895K | SH | $108.5K 0.03% | 895K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | COM NEW | 125K | SH | $70.6K 0.02% | 125K | 0.00 | 0.00 |
CONCORD ACQUISITION CORP IISOLE | *W EXP 99/99/999 | 408.33K | SH | $45.4K 0.01% | 408.33K | 0.00 | 0.00 |
COMPASS DIGITAL ACQUISITION CORPSOLE | *W EXP 09/29/202 | 459.91K | SH | $42.3K 0.01% | 459.91K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | *W EXP 03/14/202 | 655.20K | SH | $34.1K <0.01% | 655.20K | 0.00 | 0.00 |
SWIFTMERGE ACQUISITION CORPSOLE | *W EXP 12/13/202 | 490K | SH | $27.4K <0.01% | 490K | 0.00 | 0.00 |
YS BIOPHARMA CO LTDSOLE | *W EXP 03/15/202 | 490K | SH | $25.0K <0.01% | 490K | 0.00 | 0.00 |
Page 1 of 2